DE207550C - - Google Patents
Info
- Publication number
- DE207550C DE207550C DENDAT207550D DE207550DA DE207550C DE 207550 C DE207550 C DE 207550C DE NDAT207550 D DENDAT207550 D DE NDAT207550D DE 207550D A DE207550D A DE 207550DA DE 207550 C DE207550 C DE 207550C
- Authority
- DE
- Germany
- Prior art keywords
- bark
- lead
- acetic acid
- glucoside
- cascara sagrada
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 20
- 241000556215 Frangula purshiana Species 0.000 claims description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 239000010369 Cascara Substances 0.000 claims description 7
- 229940071704 cascara sagrada Drugs 0.000 claims description 7
- 229930182478 glucoside Natural products 0.000 claims description 5
- 150000008131 glucosides Chemical class 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000012675 alcoholic extract Substances 0.000 claims description 3
- 239000006286 aqueous extract Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 229940046892 lead acetate Drugs 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000002475 laxative effect Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- DTTVUKLWJFJOHO-NXTHJCGOSA-N 1,8-dihydroxy-3-methyl-6-[(3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyanthracene-9,10-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)OC1OC1=CC(O)=C(C(=O)C=2C(=CC(C)=CC=2O)C2=O)C2=C1 DTTVUKLWJFJOHO-NXTHJCGOSA-N 0.000 description 2
- 241001528249 Frangula alnus Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 241000031711 Cytophagaceae Species 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- VVEKCQAFOLKNKB-UHFFFAOYSA-N emodine Natural products C1=CC=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O VVEKCQAFOLKNKB-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- XCAUINMIESBTBL-UHFFFAOYSA-N lead(ii) sulfide Chemical compound [Pb]=S XCAUINMIESBTBL-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE207550C true DE207550C (enrdf_load_stackoverflow) |
Family
ID=469645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT207550D Active DE207550C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE207550C (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4015916A (en) * | 1975-11-28 | 1977-04-05 | Beloit Corporation | Heating and stratification device for an injection molding machine |
-
0
- DE DENDAT207550D patent/DE207550C/de active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4015916A (en) * | 1975-11-28 | 1977-04-05 | Beloit Corporation | Heating and stratification device for an injection molding machine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3022281C2 (de) | Von Alkaloiden befreiter wäßriger Extrakt aus Aconitwurzeln und diesen Extrakt als Wirkstoff enthaltende pharmazeutische Zusammensetzung | |
| DE1767098B1 (de) | Verfahren zur Gewinnung eines vasoaktiven Arzneimittels aus den Blaettern von Ginkgo biloba | |
| CH638976A5 (de) | Medikament, enthaltend p-aminobenzoesaeurederivate. | |
| DE207550C (enrdf_load_stackoverflow) | ||
| DE1467800A1 (de) | Verfahren zur Behandlung von insbesondere saponinhaltigen Pflanzen | |
| DE2240266C2 (de) | Verfahren zur Gewinnung von Lysergol und Canoclavindiacetat | |
| DE1793025A1 (de) | Flavanonderivate und Verfahren zu ihrer Herstellung | |
| DE2717062C2 (de) | Arzneimittel mit antitussiver Wirkung | |
| DE1695781C3 (de) | Psychotropes Arzneimittel | |
| DE175862C (enrdf_load_stackoverflow) | ||
| DE1037651B (de) | Verfahren zur Herstellung eines therapeutisch wirksamen Extraktes aus dem Kittharz der Apis mellifica | |
| DE605073C (de) | Verfahren zur Darstellung eines hochwirksamen Glucosides aus Helleborus niger, L. | |
| AT325783B (de) | Verfahren zum abtrennen des glykofrangulin-komplexes aus pflanzlichen rohstoffen, insbesondere aus der getrockneten rinde des faulbaumes | |
| DE119864C (enrdf_load_stackoverflow) | ||
| DE1543966C (de) | Thiamphenikol Derivat und Verfahren zu dessen Herstellung | |
| DE3327138C2 (enrdf_load_stackoverflow) | ||
| AT256336B (de) | Verfahren zur Herstellung eines Polysaccharids mit Anticancerwirkung | |
| DE2436479A1 (de) | Verfahren zur reinigung von steroidheterosiden | |
| DE2430463C2 (de) | Verfahren zur Herstellung eines angereicherten Trockenextraktes aus Pflanzen der Gattung Fumaria | |
| DE427857C (de) | Verfahren zur Herstellung eines symmetrisch substituierten Harnstoffderivates | |
| DE206467C (enrdf_load_stackoverflow) | ||
| DE448695C (de) | Verfahren zur Herstellung von Dipyridylen | |
| DE884068C (de) | Verfahren zur Herstellung chlorophyllfreier Pflanzenextrakte aus chlorophyllhaltigenPflanzen und Pflanzenteilen | |
| DE1050506B (de) | Verfahren zum Herstellen eines Wirkstoffkonzentrates aus Sennesdrogen | |
| DE2415544A1 (de) | 3,4',7-dihydroxyflavanon-dihexuronsaeuredimethylester, verfahren zu seiner herstellung und seine verwendung |